EE601 Using Dupilumab in Line With the England NICE Recommendation (TA534): Impact on the Healthcare Resource Utilization and Non-Medicine Cost

Autor: Tavi, J 1, Noonan, K 2, Kuznik, A 3, Rashid, H 4, Hudson, R 4, Hodgson, M 4, Bouguerra, H 5
Zdroj: In Value in Health December 2024 27(12) Supplement:S173-S173
Databáze: ScienceDirect
Externí odkaz: